MedTrace Logo

Design of an Intra-operative Blood Conservation Pathway at Open Myomectomy

NCT03211481 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2023-12-13

No results posted yet for this study

Summary

Uterine fibroids are benign uterine masses that can be removed through a surgical procedure called a myomectomy. Myomectomy is often associated with a significant amount of blood loss for the patient. The large volume of blood lost can increase post-operative complications and lead patients to require blood replacement (blood transfusion). To reduce the amount of blood lost during the surgical procedure and the need for blood transfusions, interventions such as medications and surgical techniques have been used. While evidence in the literature exists for these techniques, there is no standardized approach to this problem in clinical practice. The objective of this study is to create a novel intra-operative blood conservation pathway, using a modified Delphi expert consensus approach, to decrease the amount of blood lost during myomectomy.

The current study is expected to benefit patients undergoing myomectomy through an improved surgical experience, reduction in blood transfusion rates, and reduction in associated complications.

Conditions

  • Uterine Fibroid

Sponsors & Collaborators

  • Unity Health Toronto

    lead OTHER

Principal Investigators

  • Deborah Robertson, MD · Unity Health Toronto

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-13
Primary Completion
2019-06-21
Completion
2019-06-21

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03211481 on ClinicalTrials.gov